(Reuters) -Telecom Italia (TIM) said on Thursday it would give suitors for its fixed network until June 9 to improve further their multibillion euros bids for the former phone monopoly’s landline grid, in a final round of offers. TIM directors gathered on Thursday to draw a response to rival non binding approaches for its grid …
TIM makes last call on grid suitors to sweeten bids Read More »
(Reuters) -Air France-KLM said on Thursday it engaged with private equity firm Apollo Global Management for a 500 million euro ($550.70 million) capital injection for one of its engineering and maintenance units. The proceeds of the transaction would be allocated to general corporate purposes, the airline said, adding it would not involve any operational or …
Air France-KLM in talks with Apollo for $550 million cash injection Read More »
By Paul Sandle LONDON (Reuters) -Britain’s competition regulator said on Thursday it would start examining the impact of artificial intelligence on consumers, businesses and the economy and whether new controls were needed on technologies such as OpenAI’s ChatGPT. While research on AI has been going on for years, the sudden popularity of generative AI applications …
UK reviews AI models as rapid growth fuels safety concerns Read More »
PARIS (Reuters) -France’s antitrust watchdog on Thursday gave Facebook-owner Meta two months to change its access rules for ad verification partners, saying the company was potentially taking unfair advantage of a dominant market position in online advertising. In a statement, the competition authority said Meta must publish new access criteria for partners seeking to use …
French antitrust body tells Meta to change conditions for access to ad verification Read More »
By Foo Yun Chee BRUSSELS (Reuters) -Microsoft has offered to charge different prices for its Office product with and without its Teams app to stave off a possible EU antitrust investigation and fine, two people familiar with the matter said. Microsoft has been seeking to address the EU competition enforcer’s concerns since last year after …
Exclusive-Microsoft offers to charge for Teams to address EU antitrust concerns Read More »
By Emma-Victoria Farr and Oliver Hirt FRANKFURT/ZURICH (Reuters) – UBS is reviewing options for Credit Suisse’s Swiss bank, including potentially keeping the unit’s investment banking operations while selling the rest, two people familiar with the matter told Reuters. UBS is studying plans to sell the Swiss banking business of Credit Suisse in an initial public …
Exclusive-UBS weighs options for sale of Credit Suisse’s Swiss unit – sources Read More »
(Reuters) – German business software developer Software AG said on Thursday it supports private-equity firm Silver Lake Management’s increased offer to buy the company for 32 euros ($35.28) per share, ending a bidding war looming over the company. The offer values the German company at 2.37 billion euros. Software AG has received multiple offers according …
By Shristi Achar A and Amruta Khandekar (Reuters) -London’s FTSE 100 hit a one-month low on Thursday as a smaller interest rate hike by the European Central Bank did little to lift sentiment dampened by concerns about the banking sector, while Shell gained after posting upbeat earnings. The blue-chip index ended 1.1% lower, while the …
FTSE 100 at one-month low as financials drag, ECB signals more hikes Read More »
By Nikolaj Skydsgaard COPENHAGEN (Reuters) -Danish drug developer Novo Nordisk said it would have to halve the supply of starter doses of its popular Wegovy weight-loss drug in the United States to cope with high demand after reporting forecast-beating results on Thursday. Shares in Novo Nordisk traded down 4.7% at 0731 GMT, putting a small …
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand Read More »
By Nikolaj Skydsgaard and Maggie Fick COPENHAGEN/LONDON (Reuters) – Novo Nordisk is prioritising U.S. supplies of its popular weight-loss drug Wegovy over launching in new markets, a senior executive told Reuters on Thursday as the Danish drugmaker struggles to keep up with skyrocketing demand there. More than 100,000 U.S. prescriptions per week for the drug …
Novo Nordisk: U.S. is priority for weight-loss drug over launching in new markets Read More »
